MIAMI, July 23, 2026 (GLOBE NEWSWIRE) --
OPKO Health, Inc.
(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this
link
. Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations
here
.
A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations
here
.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit
www.opko.com
.
Contacts:
Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com
OPKO Health to Report Second-Quarter 2026 Financial Results on July 27 and Host Conference Call
OPKO Health will report Q2 2026 results on July 27, with a conference call scheduled for 4:30 p.m. ET.
Quiver AI Summary
OPKO Health, Inc. announced that it will report its operating and financial results for the second quarter of 2026 on July 27, 2026. The company's senior management will host a conference call and webcast at 4:30 p.m. ET to discuss the business update, financial results, and guidance. Participants are encouraged to pre-register for the call to receive a unique PIN for easier access. Those unable to pre-register can join via specified phone numbers. A replay of the call will be available until August 3, 2026, as well as a webcast replay shortly after the live event. OPKO is focused on next-generation healthcare solutions and aims to lead in rapidly growing markets through its innovative technologies.
Potential Positives
Potential Negatives
FAQ
When will OPKO Health report its financial results for Q2 2026?
OPKO Health will report its financial results on July 27, 2026.
How can I participate in the OPKO conference call?
You can participate by pre-registering or calling 833-630-0584 (U.S.) or 412-317-1815 (International).
Where can I find the webcast of the OPKO conference call?
The webcast can be accessed through OPKO’s Investor Relations page.
Is there a replay available for the OPKO conference call?
Yes, a telephone replay will be available until August 3, 2026, and a webcast replay will be accessible one hour after the live call.
What does OPKO Health focus on?
OPKO Health is focused on delivering next-generation solutions for serious diseases across established global markets.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OPK Insider Trading Activity
$OPK insiders have traded $OPK stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OPK stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$OPK Hedge Fund Activity
We have seen 82 institutional investors add shares of $OPK stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link . Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations here .
A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations here .
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com .
Contacts:
Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com
Read full article here »